WuXi XDC and Celltrion sign MoU for integrated services for Antibody-Drug Conjugates

WuXi XDC, China-based contract research, development and manufacturing organisation (CRDMO) focused on antibody drug con...

January 24, 2024 | Wednesday | News
Korea's Lotte Biologics inks deal with US-based NJ Bio for antibody drug conjugates services

South Korean firm Lotte Biologics has recently signed a strategic business agreement with NJ Bio (hereinafter refer...

January 22, 2024 | Monday | News
Korea's Samsung Electronics develops hip-assist robot to advance fitness in elderly

With the advancement of science and technology, robotics have infiltrated numerous sectors, including healthcare. Samsun...

January 18, 2024 | Thursday | News
Korean FUST Lab's DEBREX Nano-Emulsion/Dispersion equipment enters Japan market

Korean spin-off company from the Korea Research Institute of Standards and Science, FUST Lab's DEBREX Nano-Emulsion...

January 16, 2024 | Tuesday | News
Dental Bridge from South Korea marks entry into Indian market

In a significant move to advance facial aesthetics treatments in India, Dbridge India, a subsidiary of South Korea's Den...

January 15, 2024 | Monday | News
Korea designs wrist rotation module to enhance usability and efficiency in prosthetic limbs

Robotic assistive devices play a crucial role in supporting the daily activities of individuals with congenital disabili...

January 12, 2024 | Friday | News
CEPI partners with Korean biotech startup Lemonex to advance mRNA vaccine delivery

Norway-based Coalition for Epidemic Preparedness Innovations(CEPI) has partnered with Lemonex Inc. (Lemonex), a bi...

January 5, 2024 | Friday | News
Korea gives license to Euvichol-S, simplified formulation of oral cholera vaccine

The International Vaccine Institute (IVI) and EuBiologics Co have announced the licensure for export by the Korean Minis...

January 2, 2024 | Tuesday | News
“Pharma companies in South Korea will need to invest in skill development”

How is the contract manufacturing/development sector evolving in Korea? How is West leveraging opportunities in this spa...

January 5, 2024 | Friday | Opinion
“The Open Innovation Program has become a trend in the molecular diagnostics industry”

Molecular diagnostics (MDx) is a powerful tool in healthcare. Could you explain why it's considered the most effective m...

January 11, 2024 | Thursday | Opinion
Korea's LegoChem Biosciences inks $1.7 B pact with J&J for ADC development

South Korea's LegoChem Biosciences (LCB) has entered into a license agreement with Janssen Biotech, Inc. (Janssen), a Jo...

December 28, 2023 | Thursday | News
Dx&Vx to develop bio-healthcare big data platform with IT firm LG CNS in Korea

South Korea-based firm Dx&Vx will develop a bio-healthcare big data platform utilising artificial intelligence (AI)&...

December 20, 2023 | Wednesday | News
Canadian healthcare startup Lydia AI expands reach in Korea

Lydia AI, a leading Canadian health artificial intelligence (AI) company, has announced its strategic collaborations wit...

December 18, 2023 | Monday | News
South Korea's Lunit buys NZ-based Volpara Health Technologies for $193 M

South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnos...

December 15, 2023 | Friday | News
Korea, Japan and China pledge to cooperate closely on healthcare

Second Vice-Minister of Health and Welfare in South Korea, Park Minsoo attended the 16th Tripartite Health Ministers' Me...

December 13, 2023 | Wednesday | News
CEPI supports novel mRNA vaccine development in Korea to protect against future Disease X

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with Korea’s Chungbuk National U...

December 12, 2023 | Tuesday | News
Korea to inject more than KRW 250 billion in Bio-health sector next year

The Ministry of Health and Welfare of South Korea government recently held the ‘K-Bio Investment Conference&r...

December 8, 2023 | Friday | News
GC Biopharma establishes mRNA production facility in Korea

GC Biopharma, a South Korean biopharmaceutical company, has completed the construction mRNA (messenger ribonucleic acid)...

December 4, 2023 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls